Meeting Banner
Abstract #0994

Impaired Glutamatergic & GABAergic Function at Early Age in APPswe-PS1dE9 Mice: Implications for Preclinical Diagnosis of Alzheimers Disease

Vivek Tiwari1, Anant Bahadur Patel1

1NMR Microimaging and Spectroscopy, Centre for Cellular and Molecular Biology, Hyderabad, Andhra Pradesh, India

APP-PS1 mice show occasional deposits of amyloid plaques at the age of 5-6 months without significant memory impairment and neuronal loss, characteristics typical of AD pathology at early stage of the disease. Present study evaluates glutamatergic and GABAergic neurotransmitter energetics in 6 month old APPswe-PS1dE9 by using 1H-[13C]-NMR spectroscopy together with infusion of [1,6-13C2]glucose. Although APPswe-PS1dE9 mice at 6 month age exhibited no significant derangement in neurochemical profile but glucose oxidation and neurotransmitter flux associated with glutamatergic and GABAergic neurons were found to be significantly impaired.

Keywords

acids addition aging amino anesthetized animal approved available biology biotechnology blood bolus brain cellular cerebral characteristics characterized closely cognitive collected committee common concentration cortex cortical courses cycling delay deposits diagnosis disease disorders early effective enrichment ethics evaluate exhibit extract extracted extracts fasted find findings fitting flow frozen function functions funding glucose hardy head human impaired impairment implications infused infusion institute interventions investigate labeling least liquid loss marked match matched materials measured memory metabolism metabolites mice molecular month months moreover natl neuritic neuronal neurons nitrogen nonlinear objective occasional overnight oxidation paradigm pathology percentage plaques profile protocols reduced revealed science severely significantly situ spectra spectrometer spectroscopy squares stage steady suggest supported tail tangles tissue together towards treatment turnover type typical urethane variable vein wild